Letter to Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome
EBioMedicine
.
2022 Aug:82:104172.
doi: 10.1016/j.ebiom.2022.104172.
Epub 2022 Jul 15.
Author
Jürgen Durner
1
Affiliation
1
Department of Conservative Dentistry and Periodontology, University Hospital, LMU Munich Ludwig-Maximilians-University of Munich, Goethestr. 70, 80336 Munich, Germany; Laboratory Becker and Colleagues, Führichstr. 70, 81671 München, Germany. Electronic address: j.durner@labor-becker.de.
PMID:
35841875
PMCID:
PMC9297074
DOI:
10.1016/j.ebiom.2022.104172
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers
Butyrylcholinesterase
Humans
Infant
Sudden Infant Death* / diagnosis
Sudden Infant Death* / etiology
Syndrome
Substances
Biomarkers
Butyrylcholinesterase